The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) randomised controlled trial—study design and protocol

Novodvorský, P. orcid.org/0000-0002-3292-7586, Thieme, L., Laňková, I. et al. (8 more authors) (2024) The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) randomised controlled trial—study design and protocol. Diabetes Therapy, 15 (6). pp. 1461-1471. ISSN 1869-6953

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© The Author(s) 2024. Open Access: This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.

Keywords: Complex insulin therapy simplification; Fixed-ratio combination of GLP-1 receptor agonist and basal insulin (FRC); Insulin therapy de-intensification; Insulin glargine/lixisenatide (iGlarLixi); Intensified insulin therapy (IIT); Multiple daily injections insulin regimen (MDI); Type 2 diabetes (T2D)
Dates:
  • Published: June 2024
  • Published (online): 24 April 2024
  • Accepted: 2 April 2024
  • Submitted: 8 March 2024
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology and Metabolism (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 21 May 2024 16:04
Last Modified: 21 May 2024 16:04
Status: Published
Publisher: Springer Science and Business Media LLC
Refereed: Yes
Identification Number: 10.1007/s13300-024-01582-x
Open Archives Initiative ID (OAI ID):

Download

Export

Statistics